advertisement

Oculus

9.4.5.1 Neovascular glaucoma (37)

Showing records 1 to 25

Display all abstracts in classification 9.4.5.1 Neovascular glaucoma

Search within classification 9.4.5.1 Neovascular glaucoma
91699 Proteomic Study of Aqueous Humor and Its Application in the Treatment of Neovascular Glaucoma
Yu M
Frontiers in molecular biosciences 2020; 7: 587677
91743 Intravitreal Aflibercept in Japanese Patients with Neovascular Glaucoma: The VEGA Randomized Clinical Trial
Inatani M
Advances in Therapy 2021; 38: 1116-1129
91732 Various modalities for management of secondary angle closure neovascular glaucoma in diabetic eyes: 1-year comparative study
El-Saied HMA
International Ophthalmology 2021; 41: 1179-1190
91684 The incidence and risk factors of neovascular glaucoma secondary to proliferative diabetic retinopathy after vitrectomy
Sun D
European Journal of Ophthalmology 2020; 0: 1120672120980686
91677 Efficacy and Safety of Intravitreal Aflibercept Injection in Japanese Patients with Neovascular Glaucoma: Outcomes from the VENERA Study
Inatani M
Advances in Therapy 2021; 38: 1106-1115
91684 The incidence and risk factors of neovascular glaucoma secondary to proliferative diabetic retinopathy after vitrectomy
Lin Y
European Journal of Ophthalmology 2020; 0: 1120672120980686
91743 Intravitreal Aflibercept in Japanese Patients with Neovascular Glaucoma: The VEGA Randomized Clinical Trial
Higashide T
Advances in Therapy 2021; 38: 1116-1129
91677 Efficacy and Safety of Intravitreal Aflibercept Injection in Japanese Patients with Neovascular Glaucoma: Outcomes from the VENERA Study
Higashide T
Advances in Therapy 2021; 38: 1106-1115
91699 Proteomic Study of Aqueous Humor and Its Application in the Treatment of Neovascular Glaucoma
Xie F
Frontiers in molecular biosciences 2020; 7: 587677
91732 Various modalities for management of secondary angle closure neovascular glaucoma in diabetic eyes: 1-year comparative study
Abdelhakim MASE
International Ophthalmology 2021; 41: 1179-1190
91743 Intravitreal Aflibercept in Japanese Patients with Neovascular Glaucoma: The VEGA Randomized Clinical Trial
Matsushita K
Advances in Therapy 2021; 38: 1116-1129
91699 Proteomic Study of Aqueous Humor and Its Application in the Treatment of Neovascular Glaucoma
Liu X
Frontiers in molecular biosciences 2020; 7: 587677
91677 Efficacy and Safety of Intravitreal Aflibercept Injection in Japanese Patients with Neovascular Glaucoma: Outcomes from the VENERA Study
Matsushita K
Advances in Therapy 2021; 38: 1106-1115
91684 The incidence and risk factors of neovascular glaucoma secondary to proliferative diabetic retinopathy after vitrectomy
Zeng R
European Journal of Ophthalmology 2020; 0: 1120672120980686
91743 Intravitreal Aflibercept in Japanese Patients with Neovascular Glaucoma: The VEGA Randomized Clinical Trial
Miki A
Advances in Therapy 2021; 38: 1116-1129
91684 The incidence and risk factors of neovascular glaucoma secondary to proliferative diabetic retinopathy after vitrectomy
Yang Z
European Journal of Ophthalmology 2020; 0: 1120672120980686
91677 Efficacy and Safety of Intravitreal Aflibercept Injection in Japanese Patients with Neovascular Glaucoma: Outcomes from the VENERA Study
Nagasato D
Advances in Therapy 2021; 38: 1106-1115
91699 Proteomic Study of Aqueous Humor and Its Application in the Treatment of Neovascular Glaucoma
Sun H
Frontiers in molecular biosciences 2020; 7: 587677
91684 The incidence and risk factors of neovascular glaucoma secondary to proliferative diabetic retinopathy after vitrectomy
Deng X
European Journal of Ophthalmology 2020; 0: 1120672120980686
91699 Proteomic Study of Aqueous Humor and Its Application in the Treatment of Neovascular Glaucoma
Guo Z
Frontiers in molecular biosciences 2020; 7: 587677
91677 Efficacy and Safety of Intravitreal Aflibercept Injection in Japanese Patients with Neovascular Glaucoma: Outcomes from the VENERA Study
Takagi H
Advances in Therapy 2021; 38: 1106-1115
91743 Intravitreal Aflibercept in Japanese Patients with Neovascular Glaucoma: The VEGA Randomized Clinical Trial
Ueki M
Advances in Therapy 2021; 38: 1116-1129
91677 Efficacy and Safety of Intravitreal Aflibercept Injection in Japanese Patients with Neovascular Glaucoma: Outcomes from the VENERA Study
Ueki M
Advances in Therapy 2021; 38: 1106-1115
91684 The incidence and risk factors of neovascular glaucoma secondary to proliferative diabetic retinopathy after vitrectomy
Lan Y
European Journal of Ophthalmology 2020; 0: 1120672120980686
91743 Intravitreal Aflibercept in Japanese Patients with Neovascular Glaucoma: The VEGA Randomized Clinical Trial
Iwamoto Y
Advances in Therapy 2021; 38: 1116-1129

Issue 21-4

Change Issue


advertisement

Oculus